-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $95

Benzinga·04/29/2026 17:52:10
Listen to the news
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $98 to $95.